Open- | Close- |
Vol / Avg.0 / 324.587K | Mkt Cap362.919M |
Day Range- - - | 52 Wk Range3.810 - 27.920 |
IGM Biosciences Stock (NASDAQ: IGMS) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 324.587K | Mkt Cap362.919M |
Day Range- - - | 52 Wk Range3.810 - 27.920 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.220 | -1.040 | 0.1800 | ||||
REV | 780.000K | 509.000K | -271.000K |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.430 | -1.430 | 0.0000 | ||||
REV | 800.000K | 448.000K | -352.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-15 | Morgan Stanley | Michael Lapides | Maintains | Equal-WeightEqual-Weight | Lowers | 15.00 | 8.00 |
2023-11-15 | HC Wainwright & Co. | Robert Burns | Maintains | BuyBuy | Lowers | 17.00 | 11.00 |
2023-11-14 | Stifel | Stephen Willey | Maintains | BuyBuy | Lowers | 26.00 | 25.00 |
2023-11-14 | RBC Capital | Brian Abrahams | Maintains | Sector PerformSector Perform | Lowers | 11.00 | 8.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
IGMS | IGM Biosciences | 0% | 362.9M |
IMNM | Immunome | 0% | 333.3M |
ORTX | Orchard Therapeutics | -0.56% | 366.9M |
CELC | Celcuity | -2.55% | 350.9M |
VYGR | Voyager Therapeutics | 0% | 334.8M |
You can purchase shares of IGM Biosciences (NASDAQ: IGMS) through any online brokerage.
Other companies in IGM Biosciences’s space includes: Immunome (NASDAQ:IMNM), Orchard Therapeutics (NASDAQ:ORTX), Celcuity (NASDAQ:CELC), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
The latest price target for IGM Biosciences (NASDAQ: IGMS) was reported by Morgan Stanley on Wednesday, November 15, 2023. The analyst firm set a price target for 8.00 expecting IGMS to rise to within 12 months (a possible 28.72% upside). 19 analyst firms have reported ratings in the last year.
The stock price for IGM Biosciences (NASDAQ: IGMS) is $6.215 last updated December 1, 2023 at 9:00 PM UTC.
There is no dividend information for IGM Biosciences.
IGM Biosciences’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for IGM Biosciences.
IGM Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.